Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.76%72.7B | 4.65%279.18B | 1.25%68.1B | -2.68%266.79B | -2.44%64.07B | -1.01%68.22B | -2.08%67.25B | -5.12%67.26B | 4.76%274.14B | -0.16%65.67B |
| Cost of revenue | 5.98%57.24B | 3.65%223.65B | -0.40%54.01B | -3.15%215.77B | -2.93%52.07B | -1.88%54.89B | -2.49%54.58B | -5.24%54.23B | 4.23%222.79B | -0.68%53.65B |
| Gross profit | 9.74%15.46B | 8.87%55.54B | 8.11%14.08B | -0.66%51.01B | -0.27%11.99B | 2.78%13.33B | -0.27%12.66B | -4.65%13.03B | 7.11%51.35B | 2.22%12.03B |
| Operating expense | 6.15%5.83B | 9.90%22.44B | 7.45%5.5B | 3.28%20.42B | 7.74%5.01B | 2.96%5.15B | 0.92%5.14B | 1.85%5.11B | 1.81%19.77B | -2.41%4.65B |
| Operating profit | 12.04%9.62B | 8.19%33.1B | 8.53%8.59B | -3.13%30.59B | -5.32%6.98B | 2.66%8.18B | -1.07%7.52B | -8.42%7.91B | 10.72%31.58B | 5.37%7.38B |
| Net non-operating interest income (expenses) | 2,600.00%25M | 1,383.33%77M | 50.00%-1M | -200.00%-6M | 0 | -200.00%-1M | -3M | -133.33%-2M | -82.86%6M | -106.67%-1M |
| Non-operating interest income | 300.00%72M | 321.62%156M | 157.14%18M | 54.17%37M | 133.33%14M | 50.00%9M | 40.00%7M | 0.00%7M | -31.43%24M | -60.00%6M |
| Non-operating interest expense | 147.37%47M | 83.72%79M | 111.11%19M | 138.89%43M | 100.00%14M | 100.00%10M | 100.00%10M | 800.00%9M | --18M | --7M |
| Net investment income | 0.32%943M | -4.53%1.73B | -9.79%940M | 3.54%1.81B | -51.00%49M | 79.82%615M | -50.70%106M | -4.67%1.04B | 71.57%1.75B | 19.05%100M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -2.18%1.12B | 213M | 3,487.50%1.15B | 271M | 14.80%287M | 313.33%32M | 0 | ||
| Income from associates and other participating interests | 74.71%449M | 11.35%1.35B | 10.78%257M | -4.18%1.22B | 11.57%270M | -16.59%342M | 33.33%372M | -31.36%232M | 51.61%1.27B | -4.72%242M |
| Special income (charges) | -127.27%-12M | 1,239.13%308M | 309.52%44M | 116.67%23M | -78.42%41M | -72.73%3M | 0 | 85.42%-21M | 75.66%-138M | 201.59%190M |
| Less:Other special charges | 127.27%12M | -2,043.48%-493M | -309.52%-44M | -116.67%-23M | 78.42%-41M | 72.73%-3M | --0 | -85.42%21M | -54.00%138M | -201.59%-190M |
| Less:Write off | ---- | --185M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -16.15%135M | -30.05%398M | 4.55%161M | 24.51%569M | -4.40%152M | 7.48%158M | 294.44%105M | -24.88%154M | -0.44%457M | -2.45%159M |
| Income before tax | 9.40%11.16B | 7.71%38.08B | 9.51%10.2B | 1.14%35.36B | -3.71%7.77B | 5.01%9.58B | 13.93%8.69B | -8.11%9.32B | 15.41%34.96B | 6.47%8.07B |
| Income tax | 5.51%3.16B | 6.32%11.1B | 7.36%2.99B | 1.05%10.44B | -2.02%2.23B | 5.51%2.82B | 9.53%2.61B | -7.29%2.79B | 8.06%10.34B | 0.75%2.28B |
| Net income | 11.01%8B | 8.29%26.98B | 10.43%7.21B | 1.18%24.91B | -4.35%5.54B | 4.80%6.77B | 15.91%6.08B | -8.45%6.53B | 18.80%24.62B | 8.92%5.79B |
| Net income continuous operations | 11.01%8.01B | 8.30%26.98B | 10.43%7.21B | 1.18%24.91B | -4.37%5.54B | 4.80%6.77B | 15.93%6.08B | -8.45%6.53B | 18.80%24.62B | 8.90%5.79B |
| Noncontrolling interests | 108.33%25M | 136.07%44M | 271.43%12M | -4,166.67%-122M | -746.15%-110M | -300.00%-8M | -40.00%3M | -200.00%-7M | 102.24%3M | -230.00%-13M |
| Net income attributable to the company | 10.85%7.98B | 7.59%26.94B | 10.11%7.2B | 1.69%25.04B | -2.71%5.65B | 4.99%6.77B | 15.99%6.08B | -8.25%6.54B | 18.02%24.62B | 9.37%5.8B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 10.85%7.98B | 7.59%26.94B | 10.11%7.2B | 1.69%25.04B | -2.71%5.65B | 4.99%6.77B | 15.99%6.08B | -8.25%6.54B | 18.02%24.62B | 9.37%5.8B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 16.51%78.77 | 10.69%257.88 | 13.29%67.61 | 5.56%232.97 | 0.84%53.09 | 9.00%63.56 | 19.90%56.64 | -4.50%59.68 | 22.51%220.69 | 14.01%52.65 |
| Diluted earnings per share | 16.51%78.77 | 10.69%257.88 | 13.29%67.61 | 5.56%232.97 | 0.72%53.027 | 9.00%63.56 | 19.90%56.64 | -4.50%59.68 | 22.51%220.69 | 14.01%52.65 |
| Dividend per share | 0 | 30.00%130 | 0 | 11.11%100 | 10.00%55 | 0 | 12.50%45 | 0 | 23.29%90 | 8.70%50 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |